Table 7 |
|||||
|
Post-treatment changes of lymphocytes and immunoglobulins |
|||||
|
Baseline values and post-treatment percent change from baseline (mean ± SD) |
|||||
|
Baseline |
6 weeks |
10 weeks |
18 weeks |
32 weeks |
|
|
|
|||||
|
Lymphocytes |
N = 14 |
N = 6 |
N = 8 |
N = 9 |
N = 11 |
|
B cells |
123 ± 160 cells/μl |
-35% ± 23% |
-41% ± 41% |
-34% ± 23% |
-44% ± 21% |
|
T cells |
744 ± 554 cells/μl |
+16% ± 80% |
+28% ± 78% |
+47% ± 109% |
+17% ± 69% |
|
Immunoglobulins |
N = 12 |
N = 14 |
N = 10 |
N = 11 |
|
|
IgG |
1,252 ± 355 mg/dl |
+3% ± 8% |
+5% ± 13% |
+5% ± 9% |
1% ± 13% |
|
IgA |
226 ± 94 mg/dl |
+3% ± 11% |
+8 ± 13% |
+5% ± 12% |
+10% ± 20% |
|
IgM |
117 ± 73 mg/dl |
-12% ± 18% |
-1% ± 23% |
-6% ± 19% |
-9% ± 9% |
|
|
|||||
|
SD, standard deviation. |
|||||
|
Dörner et al. Arthritis Research & Therapy 2006 8:R74 doi:10.1186/ar1942 |
|||||